TR200000958T2 - The use of thiazolidinedione in the treatment of hyperglycemia. - Google Patents
The use of thiazolidinedione in the treatment of hyperglycemia.Info
- Publication number
- TR200000958T2 TR200000958T2 TR2000/00958T TR200000958T TR200000958T2 TR 200000958 T2 TR200000958 T2 TR 200000958T2 TR 2000/00958 T TR2000/00958 T TR 2000/00958T TR 200000958 T TR200000958 T TR 200000958T TR 200000958 T2 TR200000958 T2 TR 200000958T2
- Authority
- TR
- Turkey
- Prior art keywords
- hyperglycemia
- thiazolidinedione
- treatment
- mammal
- toxic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Plazma glükoz seviyelerinin yüksek normal <=126mg/dl, arasinda oldugu hiperglisemi tedavisi için, ihtiyaci olan memeliye etkili toksik olmayan ve farmasötik olarak kabul edilebilir miktarda bir ensülin sensitizörü uygulanmasini içeren bir yöntem.A method of treating hyperglycemia in which plasma glucose levels are between high normal <= 126mg / dl, and applying a non-toxic and pharmaceutically acceptable amount of insulin sensitizer to the mammal in need.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721693.1A GB9721693D0 (en) | 1997-10-13 | 1997-10-13 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200000958T2 true TR200000958T2 (en) | 2000-08-21 |
Family
ID=10820482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/00958T TR200000958T2 (en) | 1997-10-13 | 1998-10-12 | The use of thiazolidinedione in the treatment of hyperglycemia. |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1023056A1 (en) |
| JP (1) | JP2001519382A (en) |
| KR (1) | KR20010024481A (en) |
| CN (1) | CN1281359A (en) |
| AP (1) | AP2000001787A0 (en) |
| AU (1) | AU9547098A (en) |
| BG (1) | BG104404A (en) |
| BR (1) | BR9815219A (en) |
| CA (1) | CA2306086A1 (en) |
| CZ (1) | CZ20001297A3 (en) |
| EA (1) | EA002659B1 (en) |
| GB (1) | GB9721693D0 (en) |
| HR (1) | HRP20000255A2 (en) |
| HU (1) | HUP0003922A3 (en) |
| ID (1) | ID24521A (en) |
| IL (1) | IL135513A0 (en) |
| NO (1) | NO20001898L (en) |
| NZ (1) | NZ503862A (en) |
| OA (1) | OA11683A (en) |
| PL (1) | PL339813A1 (en) |
| SK (1) | SK5312000A3 (en) |
| TR (1) | TR200000958T2 (en) |
| WO (1) | WO1999018943A1 (en) |
| YU (1) | YU28800A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3856378T2 (en) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
-
1997
- 1997-10-13 GB GBGB9721693.1A patent/GB9721693D0/en not_active Ceased
-
1998
- 1998-10-12 AU AU95470/98A patent/AU9547098A/en not_active Abandoned
- 1998-10-12 HU HU0003922A patent/HUP0003922A3/en unknown
- 1998-10-12 PL PL98339813A patent/PL339813A1/en unknown
- 1998-10-12 EA EA200000419A patent/EA002659B1/en not_active IP Right Cessation
- 1998-10-12 EP EP98949086A patent/EP1023056A1/en not_active Withdrawn
- 1998-10-12 AP APAP/P/2000/001787A patent/AP2000001787A0/en unknown
- 1998-10-12 WO PCT/GB1998/003064 patent/WO1999018943A1/en not_active Ceased
- 1998-10-12 CZ CZ20001297A patent/CZ20001297A3/en unknown
- 1998-10-12 KR KR1020007003934A patent/KR20010024481A/en not_active Ceased
- 1998-10-12 CN CN98812083A patent/CN1281359A/en active Pending
- 1998-10-12 JP JP2000515578A patent/JP2001519382A/en active Pending
- 1998-10-12 BR BR9815219-0A patent/BR9815219A/en not_active Application Discontinuation
- 1998-10-12 NZ NZ503862A patent/NZ503862A/en unknown
- 1998-10-12 TR TR2000/00958T patent/TR200000958T2/en unknown
- 1998-10-12 IL IL13551398A patent/IL135513A0/en unknown
- 1998-10-12 ID IDW20000669A patent/ID24521A/en unknown
- 1998-10-12 HR HR20000255A patent/HRP20000255A2/en not_active Application Discontinuation
- 1998-10-12 SK SK531-2000A patent/SK5312000A3/en unknown
- 1998-10-12 OA OA1200000108A patent/OA11683A/en unknown
- 1998-10-12 YU YU28800A patent/YU28800A/en unknown
- 1998-10-12 CA CA002306086A patent/CA2306086A1/en not_active Abandoned
-
2000
- 2000-04-12 NO NO20001898A patent/NO20001898L/en not_active Application Discontinuation
- 2000-05-05 BG BG104404A patent/BG104404A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010024481A (en) | 2001-03-26 |
| IL135513A0 (en) | 2001-05-20 |
| AU9547098A (en) | 1999-05-03 |
| EA002659B1 (en) | 2002-08-29 |
| CN1281359A (en) | 2001-01-24 |
| HRP20000255A2 (en) | 2001-02-28 |
| EP1023056A1 (en) | 2000-08-02 |
| NO20001898L (en) | 2000-06-09 |
| BR9815219A (en) | 2001-01-02 |
| CZ20001297A3 (en) | 2001-08-15 |
| PL339813A1 (en) | 2001-01-02 |
| HUP0003922A3 (en) | 2001-12-28 |
| HUP0003922A2 (en) | 2001-10-28 |
| NZ503862A (en) | 2003-01-31 |
| NO20001898D0 (en) | 2000-04-12 |
| BG104404A (en) | 2000-12-29 |
| EA200000419A1 (en) | 2000-10-30 |
| ID24521A (en) | 2000-07-20 |
| OA11683A (en) | 2005-01-12 |
| CA2306086A1 (en) | 1999-04-22 |
| YU28800A (en) | 2003-02-28 |
| JP2001519382A (en) | 2001-10-23 |
| WO1999018943A1 (en) | 1999-04-22 |
| SK5312000A3 (en) | 2000-09-12 |
| AP2000001787A0 (en) | 2000-06-30 |
| GB9721693D0 (en) | 1997-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG127714A1 (en) | Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes | |
| EA200101089A1 (en) | NEW METHOD OF TREATMENT | |
| DK1373215T3 (en) | Gelanamycin derivatives suitable for the treatment of cancer | |
| BR0308904A (en) | Method of treatment of gastroparesis and use of a glp-1 compound | |
| DK1333887T3 (en) | Combination therapy including antidiabetic and anticonvulsant agents | |
| TR199903057T2 (en) | Treatment of diabetes with thiazolidinedione and metformin. | |
| MXPA04001525A (en) | Glucagon-like peptide-1 analogs. | |
| TR200101174T2 (en) | 5HT1, receptor agonists and metoclopramide for migraine treatment. | |
| IL143569A0 (en) | A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes | |
| BR0311161A (en) | Diabetes Treatment Method | |
| MY155219A (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
| TR199903095T2 (en) | Treatment of diabetes with rosiglitazone and insulin. | |
| TR200000958T2 (en) | The use of thiazolidinedione in the treatment of hyperglycemia. | |
| NO996270L (en) | Treatment of diabetes with thiazolidinedione and <alfa> glucosidase inhibitor | |
| AP2000001735A0 (en) | Treatment of diabetes with thiazolidinedione insulin secretagogue and alpha glucocidase inhibitor. | |
| TR200000135T2 (en) | Diabetes treatment with thiazolidinedione and sulfonylurea. | |
| TR200101336T2 (en) | Combinations with a beta-agonist and another antidiabetic agent | |
| MY125855A (en) | Treatment of diabetes with a thiazolidinedione and sulphonylurea | |
| TR200000957T2 (en) | The use of thiazolidinedione in the treatment of hyperglycemia | |
| NO20003813L (en) | Procedures for reducing or preventing pain when using spicamycin or its derivatives | |
| TR200202033T2 (en) | Preparations and Methods for Epilepsy Treatment | |
| AU4193800A (en) | Use of tagatose to enhance key blood factors | |
| WO2001047509A3 (en) | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions | |
| TR199801133T2 (en) | Nitric oxide (NO) synthase inhibitor for the treatment or prevention of type II diabetes | |
| UA36485A (en) | METHOD OF TREATMENT OF GENERALIZED PERIODONTITIS |